IP Library Assignment 073683/0099
Patent Assignment
Reel/Frame 073683/0099

Release of Security Interest

Recorded: 2025-11-21 Pages: 9
Assignor
Assignee
CENTREXION THERAPEUTICS CORPORATION
ONE BOSTON PLACE, SUITE 3520, BOSTON, MASSACHUSETTS, 02108
Covered Properties (47)
Injectable Resiniferatoxin
Application: 15/363,475 →
Publication: US US20170266139A1
Stable Aqueous Capsaicin Injectable Formulations and Medical Uses Thereof
Application: 17/701,160 →
Publication: US 2022/0211649
High Concentration Local Anesthetic Formulations
Application: 14/483,839 →
Publication: US US20150018387A1
Capsaicinoids for Use in Treating Acral Lick Granuloma
Application: 16/937,810 →
Publication: US US20210145772A1
Novel (Cyano-Dimethyl-Methyl)-Isoxazoles and -[1,3,4]Thiadiazoles
Application: 17/398,155 →
Publication: US US20220135554A1
Capsaicin Sequential Dosing Method for Treatment of Morton's Neuroma Pain
Application: 16/751,844 →
Publication: US US20200297670A1
Cyclic Pyrimidin-4-Carboxamides as CCR2 Receptor Antagonists for Treatment of Inflammation, Asthma and Copd
Application: 13/140,591 →
Publication: US US20120053164A1
Capsaicin Sequential Dosing Method for Treatment of Morton's Neuroma Pain
Application: 16/070,889 →
Publication: US US20190022036A1
Methods and Compositions for Treatment of Pain Using Capsaicin
Application: 17/339,414 →
Publication: US US20210299072A1
Injectable Resiniferatoxin
Application: 16/737,557 →
Publication: US US20200375926A1
CCR2 Receptor Antagonists and Uses Thereof
Application: 17/345,110 →
Publication: US US20220002310A1
Injectable Resiniferatoxin
Application: 13/862,260 →
Publication: US US20130303620A1
Capsaicinoids for Use in Treating ACRAL Lick Granuloma
Application: 15/524,843 →
Publication: US US20180311189A1
Compositions and Methods for Intrathecal Administration of Mcoppb for Pain Relief
Application: 17/327,888 →
Publication: US US20210386728A1
(Cyano-Dimethyl-Methyl)-Isoxazoles and -[1,3,4]Thiadiazoles
Patent: 8,865,744 →
Application: 14/278,064 →
Novel (Cyano-Dimethyl-Methyl)-Isoxazoles and -[1,3,4]Thiadiazoles
Application: 15/491,035 →
Publication: US US20170320868A1
Stable Aqueous Capsaicin Injectable Formulations and Medical Uses Thereof
Application: 16/342,652 →
Publication: US US20200046656A1
(4-((3R,4R)-3-Methoxytetrahydro-Pyran-4-Ylamino)Piperidin-1-Yl)(5-Methyl-6-(((2R,6S)-6-(P-Tolyl)Tetrahydro-2H-Pyran-2-Yl)Methylamino)Pyrimidin-4-Yl)Methanone Citrate
Application: 16/224,902 →
Publication: US US20190262339A1
(4-((3R,4R)-3-Methoxytetrahydro-Pyran-4-Ylamino)Piperidin-1-Yl)(5-Methyl-6-(((2R,6S)-6-(P-Tolyl)Tetrahydro-2H-Pyran-2-Yl)Methylamino)Pyrimidin-4-Yl)Methanone Citrate
Application: 16/787,433 →
Publication: US US20200276197A1
Capsaicinoid Prodrug Compounds and Their Use in Treating Medical Conditions
Application: 16/745,689 →
Methods and Compositions for Treatment of Pain Using Capsaicin
Application: 16/984,384 →
Publication: US US20200360314A1
Infiltration of Capsaicin into Surgical Sites and Open Wounds
Patent: 8,367,733 →
Application: 11/499,989 →
Publication: US US20060269628A1
Novel (Cyano-Dimethyl-Methyl)-Isoxazoles and -[1,3,4]Thiadiazoles
Patent: 9,650,370 →
Application: 14/891,051 →
Publication: US US20160102085A1
New CCR2 Receptor Antagonists and Uses Thereof
Application: 15/606,749 →
Publication: US US20170362249A1
(4-((3R,4R)-3-Methoxytetrahydro-Pyran-4-Ylamino)Piperidin-1-Yl)(5-Methyl-6-(((2R,6S)-6-(P-Tolyl)Tetrahydro-2H-Pyran-2-Yl)Methylamino)Pyrimidin-4-Yl)Methanone Citrate
Application: 15/849,929 →
Publication: US US20180207157A1
Stable Aqueous Capsaicin Injectable Formulations and Medical Uses Thereof
Application: 16/695,831 →
Publication: US US20200093766A1
High Concentration Local Anesthetic Formulations
Patent: 9,370,500 →
Application: 13/401,088 →
Publication: US US20120149779A1
New Somatostatin receptor subtype 4 (SSTR4) agonists
Patent: 9,371,282 →
Application: 14/275,879 →
Publication: US US20140343065A1
New CCR2 Receptor Antagonists and Uses Thereof
Patent: 9,670,222 →
Application: 14/260,552 →
Publication: US US20140235661A1
Instillation Administration of Capsaicinoids for the Treatment of Pain
Patent: 8,158,682 →
Application: 12/559,071 →
Publication: US US20100234470A1
Process and Intermediates for the Production of CCR2 Antagonists
Patent: 9,067,951 →
Application: 14/445,137 →
Publication: US US20140336374A1
New Somatostatin Receptor Subtype 4 (SSTR4) Agonists
Patent: 9,789,082 →
Application: 15/157,624 →
Publication: US US20170014381A1
Stable Aqueous Capsaicin Injectable Formulations and Medical Uses Thereof
Application: 16/695,824 →
Publication: US 2020/0093765
Novel (Cyano-Dimethyl-Methyl)-Isoxazoles and -[1,3,4]Thiadiazoles
Application: 16/749,412 →
Publication: US US20200262830A1
High Concentration Local Anesthetic Formulations
Patent: 8,119,694 →
Application: 12/542,365 →
Publication: US US20100041765A1
Cyclic Pyrimidin-4-Carboxamides as CCR2 Receptor Antagonists for Treatment of Inflammation, Asthma and Copd
Patent: 8,835,440 →
Application: 13/949,696 →
Publication: US US20130324517A1
Somatostatin Receptor Subtype 4 (SSTR4) Agonists
Application: 15/685,588 →
Publication: US US20180092880A1
High Concentration Local Anesthetic Formulations
Application: 15/835,935 →
Publication: US US20180296506A1
Compositions and Methods for Intrathecal Administration of Mcoppb for Pain Relief
Application: 16/589,218 →
Stable Aqueous Capsaicin Injectable Formulations and Medical Uses Thereof
Application: 17/018,148 →
Publication: US 2021/0052522
High Concentration Local Anesthetic Formulations
Application: 17/004,665 →
Publication: US US20210177782A1
New CCR2 Receptor Antagonists and Uses Thereof
Patent: 8,765,949 →
Application: 12/969,745 →
Publication: US US20120004252A1
Novel (Cyano-Dimethyl-Methyl)-Isoxazoles and -[1,3,4]Thiadiazoles
Application: 16/143,523 →
Publication: US US20190161481A1
CCR2 Receptor Antagonists and Uses Thereof
Application: 16/233,315 →
Publication: US US20190300541A1
Capsaicinoid Prodrug Compounds and Their Use in Treating Medical Conditions
Application: 16/745,636 →
Injectable capsaicin
Patent: 8,420,600 →
Application: 11/499,995 →
Publication: US US20070036876A1
Stable Aqueous Capsaicin Injectable Formulations and Medical Uses Thereof
Application: 16/400,278 →
Publication: US 2019/0254996
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 10, 2011
From: EBEL, HEINER; FRATTINI, SARA; GIOVANNINI, RICCARDO; HOENKE, CHRISTOPH
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 026725/0198 →
Assignment of Assignor's Interest Apr 17, 2013
From: ALGORX PHARMACEUTICALS, INC.; ANESIVA INC.
To: ARCION THERAPEUTICS, INC.
Reel/Frame 030236/0225 →
Assignment of Assignor's Interest Apr 17, 2013
From: ARCION THERAPEUTICS, INC.
To: VALLINEX, INC.
Reel/Frame 030236/0267 →
Assignment of Assignor's Interest Apr 17, 2013
From: BURCH, RONALD M.; CARTER, RICHARD B.; LAZAR, JEFFREY D.
To: ALGORX PHARMACEUTICALS, INC.
Reel/Frame 030236/0217 →
Merger Feb 26, 2014
From: VALLINEX, INC.
To: CENTREXION I, INC., C/O CENTREXION CORPORATION
Reel/Frame 032302/0737 →
Corrective Assignment to Correct the Assignee Previously Recorded at Reel: 032302 Frame: 0737. Assignor(S) Hereby Confirms the Merger. May 20, 2014
From: VALLINEX, INC.
To: CENTREXION I, INC.
Reel/Frame 032937/0699 →
Assignment of Assignor's Interest Aug 7, 2014
From: RIETHER, DORIS; BINDER, FLORIAN PAUL CHRISTIAN; DOODS, HENRI; MUELLER, STEPHAN GEORG
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 033487/0150 →
Assignment of Assignor's Interest Sep 29, 2014
From: CAMPBELL, JAMES N.; MICHAELIS, ARTHUR F.
To: ARCION THERAPEUTICS, INC.
Reel/Frame 033836/0251 →
Merger and Change of Name Sep 29, 2014
From: VALLINEX, INC.; CENTREXION I MERGER SUB, INC.; CENTREXION I, INC.
To: CONTREXION I, INC.
Reel/Frame 033836/0262 →
Assignment of Assignor's Interest Sep 29, 2014
From: ARCION THERAPEUTICS, INC.
To: VALLINEX, INC.
Reel/Frame 033836/0255 →
Assignment of Assignor's Interest Aug 20, 2015
From: CENTREXION I, INC.
To: CENTREXION THERAPEUTICS CORPORATION
Reel/Frame 036383/0765 →
Assignment of Assignor's Interest Dec 11, 2015
From: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
To: CENTREXION THERAPEUTICS CORPORATION
Reel/Frame 037273/0181 →
Assignment of Assignor's Interest Apr 6, 2016
From: CENTREXION I, INC.
To: CENTREXION THERAPEUTICS CORPORATION
Reel/Frame 038207/0784 →
Assignment of Assignor's Interest Oct 7, 2016
From: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
To: CENTREXION THERAPEUTICS CORPORATION
Reel/Frame 039967/0644 →
Assignment of Assignor's Interest Aug 31, 2018
From: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
To: CENTREXION THERAPEUTICS CORPORATION
Reel/Frame 046765/0525 →
Assignment of Assignor's Interest Aug 31, 2018
From: RIETHER, DORIS; BINDER, FLORIAN PAUL CHRISTIAN; DOODS, HENRI; MUELLER, STEPHAN GEORG
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 046993/0952 →
Assignment of Assignor's Interest Sep 18, 2018
From: RIETHER, DORIS; BINDER, FLORIAN PAUL CHRISTIAN; DOODS, HENRI; MUELLER, STEPHAN GEORG
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 046895/0248 →
Assignment of Assignor's Interest Oct 5, 2018
From: ALGORX PHARMACEUTICALS, INC.; ANESIVA INC.
To: ARCION THERAPEUTICS, INC.
Reel/Frame 047084/0156 →
Assignment of Assignor's Interest Oct 5, 2018
From: BURCH, RONALD M.; CARTER, RICHARD B.; LAZAR, JEFFREY D.
To: ALGORX PHARMACEUTICALS, INC.
Reel/Frame 047083/0817 →
Merger Oct 5, 2018
From: VALLINEX, INC.
To: CENTREXION I, INC.
Reel/Frame 047083/0784 →
Assignment of Assignor's Interest Oct 5, 2018
From: CENTREXION I, INC.
To: CENTREXION THERAPEUTICS CORPORATION
Reel/Frame 047083/0920 →
Assignment of Assignor's Interest Oct 5, 2018
From: ARCION THERAPEUTICS, INC.
To: VALLINEX, INC.
Reel/Frame 047083/0837 →
Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 033836 Frame: 0262. Assignor(S) Hereby Confirms the Merger. Jan 4, 2019
From: VALLINEX, INC.
To: CENTREXION I, INC.
Reel/Frame 048295/0441 →
Corrective Assignment to Correct the Assignee's Name and the Assignor's Name Previously Recorded at Reel: 043592 Frame: 0860. Assignor(S) Hereby Confirms the Assignment. Jan 4, 2019
From: CAMPBELL, JAMES N.; HANSON, PETER D.
To: CENTREXION THERAPEUTICS CORPORATION
Reel/Frame 048010/0181 →
Assignment of Assignor's Interest Jul 15, 2019
From: MUSSO AND ASSOCIATES LLC
To: CENTREXION THERAPEUTICS CORPORATION
Reel/Frame 049755/0181 →